Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.

MLA

Tong, Zhimin, et al. “Antitumor Effects of Cyclin Dependent Kinase 9 Inhibition in Esophageal Adenocarcinoma.” Oncotarget, vol. 8, no. 17, Apr. 2017, pp. 28696–710. EBSCOhost, https://doi.org/10.18632/oncotarget.15645.

APA

Tong, Z., Chatterjee, D., Deng, D., Veeranki, O., Mejia, A., Ajani, J. A., Hofstetter, W., Lin, S., Guha, S., Kopetz, S., Krishnan, S., & Maru, D. (2017). Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget, 8(17), 28696–28710. https://doi.org/10.18632/oncotarget.15645

Chicago

Tong, Zhimin, Devkumar Chatterjee, Defeng Deng, Omkara Veeranki, Alicia Mejia, Jaffer A Ajani, Wayne Hofstetter, et al. 2017. “Antitumor Effects of Cyclin Dependent Kinase 9 Inhibition in Esophageal Adenocarcinoma.” Oncotarget 8 (17): 28696–710. doi:10.18632/oncotarget.15645.